Halozyme Picks Up Antares' Drug Delivery Tech for Nearly $1B

Halozyme Picks Up Antares' Drug Delivery Tech for Nearly $1B

Source: 
BioSpace
snippet: 

Halozyme Therapeutics announced Wednesday morning that it is acquiring Antares Pharma for $960 million in cash. The news caused Antares stock to rocket 47% in premarket trading.